AlphaFold2 protein structure prediction: Implications for drug discovery
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The drug discovery process involves designing compounds to selectively interact with their targets. The majority of therapeutic targets for low molecular weight (small molecule) drugs are proteins. The outstanding accuracy with which recent artificial intelligence methods compile the three dimensional structure of proteins has made protein targets more accessible to the drug design process. Here we present our perspective of the significance of accurate protein structure prediction on various stages of the small molecule drug discovery life cycle focusing on current capabilities and assessing how further evolution of such predictive procedures can have a more decisive impact in the discovery of new medicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
ColabFold - Making protein folding accessible to all
Mirdita, M., Schütze, K., Moriwaki, Y., Heo, L., Ovchinnikov, S., & Steinegger, M. (2021) · doi:10.1101/2021.08.15.456425 · Cited by 9,391
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., Yuan, D., Stroe, O., Wood, G., Laydon, A., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1061 · Cited by 7,850
UniProt: the universal protein knowledgebase in 2021
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, E., Bowler-Barnett, E. H., Britto, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1100 · Cited by 6,372
Accurate prediction of protein structures and interactions using a 3-track network
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021) · doi:10.1101/2021.06.14.448402 · Cited by 5,549
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
Protein complex prediction with AlphaFold-Multimer
Evans, R., O’Neill, M., Pritzel, A., Antropova, N., Senior, A., Green, T., Žídek, A., Bates, R., Blackwell, S., Yim, J., et al. (2021) · doi:10.1101/2021.10.04.463034 · Cited by 3,808
Highly accurate protein structure prediction for the human proteome
Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., Žídek, A., Bridgland, A., Cowie, A., Meyer, C., Laydon, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03828-1 · Cited by 3,025
Fast and accurate protein structure search with Foldseek
van Kempen, M., Kim, S. S., Tumescheit, C., Mirdita, M., Lee, J., Gilchrist, C. L. M., Söding, J., & Steinegger, M. (2022) · doi:10.1101/2022.02.07.479398 · Cited by 2,598
Research works printed but not linked: 26
- Vincent, 2022, Phenotypic drug discovery: recent successes, lessons learned and new directions, Nat Rev Drug Discov, 21, 541, 10.1038/s41573-022-00503-6 · doi:10.1038/s41573-022-00503-6
- Sayers, 2022, Karsch-MizrachiI GenBank, Nucleic Acids Res, 50, D161, 10.1093/nar/gkab1135 · DOI · Paper page
- Goodsell, 2020, RCSB Protein Data Bank: Enabling biomedical research and drug discovery, Protein Sci, 29, 52, 10.1002/pro.3730 · DOI · Paper page
- Ricci-Lopez, 2021, Improving structure-based virtual screening with Ensemble docking and machine learning, J Chem Inf Model, 61, 5362, 10.1021/acs.jcim.1c00511 · DOI · Paper page
- Haley, 2020, Functional genomics for cancer drug target discovery, Cancer Cell, 38, 31, 10.1016/j.ccell.2020.04.006 · DOI
- Kim, 2020, Artificial intelligence in drug discovery: a Comprehensive review of data-driven and machine learning approaches, Biotechnol Bioproc Eng, 25, 895, 10.1007/s12257-020-0049-y · DOI · Paper page
- Attwood, 2020, Soluble ligands as drug targets, Nat Rev Drug Discov, 19, 695, 10.1038/s41573-020-0078-4 · DOI
- Goulet, 2022, Structure prediction and analysis of Hepatitis E virus non-structural proteins from the Replication and Transcription Machinery by AlphaFold2, Viruses, 14, 1537, 10.3390/v14071537 · DOI
- Goodsell, 2021, The AutoDock suite at 30, Protein Sci, 30, 31, 10.1002/pro.3934 · DOI · Paper page
- Armstrong, 2020, PDBe: improved findability of macromolecular structure data in the PDB, Nucleic Acids Res, 48, D335
- Hekkelman, 2021, AlphaFill: enriching the AlphaFold models with ligands and co-factors, bioRxiv, 11
- Hu, 2022, Lasanajak Y, Smith DF, Crawford SE, EstesMK, Venkataram Prasad BV Novel fold of rotavirus glycan-binding domain predicted by AlphaFold2 and determined by X-ray crystallography, Commun Biol, 5, 419, 10.1038/s42003-022-03357-1 · DOI
- Liebeschuetz, 2012, Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test, J Comput Aided Mol Des, 26, 737, 10.1007/s10822-012-9551-4 · DOI · Paper page
- Clark, JJ, Orban, ZJ, and Carlson, HA : Predicting binding sites from unbound versus, bound protein structures. Sci Rep 10:15856- · DOI · Paper page
- Tang, 2022, Discovery of a Novel Class of d-amino acid Oxidase Inhibitors using the Schrödinger computational platform, J Med Chem, 65, 6775, 10.1021/acs.jmedchem.2c00118 · DOI
- Das, 2021, CATH functional families predict functional sites in proteins, Bioinformatics, 37, 1099, 10.1093/bioinformatics/btaa937 · DOI
- Zięba, 2022, Kaczor AA what are the challenges with multi-targeted drug design for complex diseases?, Expet Opin Drug Discov, 17, 673, 10.1080/17460441.2022.2072827 · DOI
- de Beer, 2014, Laskowski R A PDBsum additions, Nucleic Acids Res, 42, D292, 10.1093/nar/gkt940 · DOI · Paper page
- Bryda, 2013, The Mighty Mouse: the impact of rodents on advances in biomedical research, Mo Med, 110, 207
- Pehlivanovic, 2019, Animal models in modern biomedical research, Eur J Pharm Med Res, 6, 35
- Riziotis, 2022, Thornton JM.:Capturing the geometry, function, and evolution of enzymes with 3D templates, Protein Sci, 31, 10.1002/pro.4363 · DOI
- Miller, 2021, Moving beyond static snapshots: protein dynamics and the protein data bank, J Biol Chem, 296, 100749, 10.1016/j.jbc.2021.100749 · DOI · Paper page
- Kumar, 2020, vol. 59, 57
- Stein, 2021, Modeling Alternate conformations with Alphafold2 via modification of the multiple sequence Alignment, bioRxiv
- Jones, 2022, Thornton JM :The impact of AlphaFold2 one year on, Nat Methods, 19, 15, 10.1038/s41592-021-01365-3 · DOI · Paper page
- Kuzmanic, 2020, Investigating cryptic binding sites by molecular dynamics Simulations Acc. Chem, Res, 53, 654
Cited by
High-throughput prediction of protein conformational distributions with subsampled AlphaFold2
Monteiro da Silva, G., Cui, J. Y., Dalgarno, D. C., Lisi, G. P., & Rubenstein, B. M. (2024) · Nature Communications · doi:10.1038/s41467-024-46715-9 · Cited by 196
“Moreover, methods that can rapidly predict multiple conformations may have the potential to revolutionize drug dis-coveryby uncoveringsubstantially moredrugtargets 22 .”
Exploring structural diversity across the protein universe with The Encyclopedia of Domains
Lau, A. M., Bordin, N., Kandathil, S. M., Sillitoe, I., Waman, V. P., Wells, J., Orengo, C. A., & Jones, D. T. (2024) · Science · doi:10.1126/science.adq4946 · Cited by 140
Towards evidence-based practice 2.0: leveraging artificial intelligence in healthcare
Nilsen, P., Sundemo, D., Heintz, F., Neher, M., Nygren, J., Svedberg, P., & Petersson, L. (2024) · Frontiers in Health Services · doi:10.3389/frhs.2024.1368030 · Cited by 39
“Leveraging AI-driven tools like Alphafold, researchers can predict the three-dimensional structure of amino acids, expediting the identi fi cation of promising compound candidates during the preclinical phase (41, 42).”
BackgroundMethodChallenges in bridging the gap between protein structure prediction and functional interpretation
Varadi, M., Tsenkov, M., & Velankar, S. (2025) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26614 · Cited by 36
GTalign: spatial index-driven protein structure alignment, superposition, and search
(2024) · doi:10.1038/s41467-024-51669-z · Cited by 23
Metadata
- Authors
- Borkakoti, N., & Thornton, J. M.
- Venue
- Current Opinion in Structural Biology
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 78
- Pages
- 102526
- ISSN
- 0959-440X (ISSN-L)
- OpenAlex
- W4313654640
- Cited by
- 128
- References
- 28
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AlphaFold2 protein structure prediction: Implications for drug discovery. https://app.cochat.ai/papers/10.1016/j.sbi.2022.102526
- The paper
- Borkakoti, N., & Thornton, J. M. (2023). AlphaFold2 protein structure prediction: Implications for drug discovery. Current Opinion in Structural Biology. https://doi.org/10.1016/j.sbi.2022.102526
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.